Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis

Objective: Eluxadoline is a newly approved drug for irritable bowel syndrome (IBS), but it has rarely been compared with positive controls. We aimed to compare eluxadoline with antispasmodics in the treatment of IBS. Methods: We searched the OVID Medline, Embase, and the Cochrane Central Register of...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Di, Tao, Qing-Feng, Huang, Shi-Le, Chen, Min, Zheng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906885/
https://www.ncbi.nlm.nih.gov/pubmed/35281934
http://dx.doi.org/10.3389/fphar.2022.757969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906885/
https://www.ncbi.nlm.nih.gov/pubmed/35281934
http://dx.doi.org/10.3389/fphar.2022.757969

Ejemplares similares